LA BELLA, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 12.952
EU - Europa 6.403
AS - Asia 5.315
SA - Sud America 742
Continente sconosciuto - Info sul continente non disponibili 499
AF - Africa 176
OC - Oceania 26
Totale 26.113
Nazione #
US - Stati Uniti d'America 12.751
SG - Singapore 1.926
RU - Federazione Russa 1.573
IT - Italia 1.499
CN - Cina 1.300
BR - Brasile 581
HK - Hong Kong 580
FI - Finlandia 571
UA - Ucraina 545
VN - Vietnam 516
DE - Germania 515
GB - Regno Unito 367
PL - Polonia 344
IE - Irlanda 267
FR - Francia 245
JP - Giappone 214
BD - Bangladesh 162
SE - Svezia 141
IN - India 134
KR - Corea 121
CA - Canada 101
NL - Olanda 76
BE - Belgio 63
AR - Argentina 60
IQ - Iraq 58
RO - Romania 51
TR - Turchia 44
CI - Costa d'Avorio 42
MX - Messico 41
ES - Italia 37
ZA - Sudafrica 31
AT - Austria 30
PK - Pakistan 30
SA - Arabia Saudita 26
AU - Australia 25
PH - Filippine 25
UZ - Uzbekistan 24
CO - Colombia 23
MY - Malesia 23
EC - Ecuador 20
EG - Egitto 20
ID - Indonesia 20
IR - Iran 19
VE - Venezuela 19
MA - Marocco 18
TN - Tunisia 14
CH - Svizzera 13
NG - Nigeria 13
CL - Cile 12
JM - Giamaica 12
GR - Grecia 11
JO - Giordania 10
KE - Kenya 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
HN - Honduras 8
IL - Israele 8
PY - Paraguay 8
AZ - Azerbaigian 7
BO - Bolivia 7
DZ - Algeria 7
GT - Guatemala 7
KZ - Kazakistan 7
OM - Oman 7
CR - Costa Rica 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
NI - Nicaragua 6
NO - Norvegia 6
PE - Perù 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
NP - Nepal 5
TH - Thailandia 5
AL - Albania 4
EU - Europa 4
HR - Croazia 4
LB - Libano 4
SN - Senegal 4
SV - El Salvador 4
UY - Uruguay 4
BH - Bahrain 3
HU - Ungheria 3
LT - Lituania 3
RS - Serbia 3
SD - Sudan 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BY - Bielorussia 2
GA - Gabon 2
GY - Guiana 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
MU - Mauritius 2
Totale 25.598
Città #
Ashburn 1.575
Singapore 1.299
Fairfield 1.264
San Jose 806
Woodbridge 753
Chandler 729
Houston 570
Wilmington 552
Hong Kong 546
Seattle 526
Ann Arbor 519
Cambridge 407
Jacksonville 301
Zgierz 295
Moscow 271
Dublin 257
Dallas 231
Beijing 229
Palermo 211
Medford 203
Council Bluffs 198
Santa Clara 198
Tokyo 197
Frankfurt am Main 195
Los Angeles 177
Des Moines 173
Ho Chi Minh City 167
Nanjing 153
New York 143
Princeton 137
Hanoi 135
Lauterbourg 132
Boardman 129
The Dalles 111
Milan 106
Altamura 104
Lawrence 92
Dearborn 90
San Diego 87
Tulsa 82
Chicago 74
Buffalo 72
São Paulo 64
Hefei 63
Helsinki 62
Brussels 56
London 53
Hebei 51
Nanchang 50
Jinan 46
Venice 44
Shenyang 43
Abidjan 42
Atlanta 41
Ludwigshafen am Rhein 39
Rome 38
Falls Church 37
Orem 36
Changsha 34
Phoenix 31
Ningbo 30
Da Nang 29
North Bergen 29
Norwalk 29
Tianjin 29
Verona 29
Warsaw 29
Columbus 28
Montreal 28
Guangzhou 27
Piscataway 27
Denver 26
Washington 26
Zhengzhou 26
Chennai 25
Seongnam 25
Toronto 25
Rio de Janeiro 23
Hangzhou 22
Haiphong 21
Saint Petersburg 21
Stockholm 21
Turin 21
Clifton 20
San Paolo di Civitate 20
Dhaka 19
Jiaxing 19
Newark 19
Nuremberg 19
Salt Lake City 19
San Francisco 19
Tashkent 19
Baghdad 18
Brooklyn 18
Cardiff 17
Johannesburg 17
Mumbai 17
Secaucus 17
Boston 16
Bremen 16
Totale 16.231
Nome #
INDIVIDUAL AND HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS AND THEIR CAREGIVERS 457
A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia 423
Plasma cortisol level in amyotrophic lateral sclerosis 365
Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. 338
The MITOS system predicts long-term survival in amyotrophic lateral sclerosis 337
A Human-Humanoid Interaction through the use of BCI for Locked-In ALS Patients using neuro-biological feedback fusion 311
INCIDENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN SICILY: A POPULATION BASED STUDY. 309
CLINICAL CHARACTERISTICS OF PATIENTS WITH FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS CARRYING THE PATHOGENIC GGGGCC HEXANUCLEOTIDE REPEAT EXPANSION OF C9ORF72 290
FACTORS AFFECTING THE DIAGNOSTIC DELAY IN AMYOTROPHIC LATERAL SCLEROSIS 290
Reaching and grasping a glass of water by locked-In ALS patients through a BCI-controlled humanoid robot 280
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. 274
FUS MUTATIONS IN SPORADIC AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL AND GENETIC ANALYSIS 264
Causes and place of death in Italian patients with amyotrophic lateral sclerosis 257
Ethical issues: invasive ventilation in amyotrophic lateral sclerosis 253
A CERVICAL MYELOPATHY WITH A HIRAYAMA DISEASE-LIKE PHENOTYPE 247
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 244
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. 241
TELEPHONE FOLLOW-UP FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS 240
NONINVASIVE POSITIVE-PRESSURE VENTILATION IN ALS. Predictors of tolerance and survival 237
FATIGUE, SLEEP, AND NOCTURNAL COMPLAINTS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. 237
TRACHEOSTOMY MECHANICAL VENTILATION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL FEATURES AND SURVIVAL ANALYSIS. 234
REM sleep behavior disorder and periodic leg movements during sleep in ALS 231
Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. 229
ACUTE REVERSIBLE PARKINSONISM IN A DIABETIC UREMIC PATIENT 228
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation 228
Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis. 227
ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic FUS P525L Mutation Carriers 227
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 226
Dysembryoplastic Neuroepithelial Tumor of the brainstem 225
DEVELOPMENT OF CHRONIC HYPOVENTILATION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS 225
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 224
ACUTE REVERSIBLE PARKINSONISM IN A DIABETIC-UREMIC PATIENT 224
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex 219
C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSIONS IN THE ITALIAN SPORADIC ALS POPULATION. 217
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in Amyotrophic Lateral Sclerosis 209
Cerebral Venous Sinus Espansion in Post Puncture Headache 208
ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles 207
The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. 206
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 203
EXPRESSION OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN-ASSOCIATED PROTEIN B CLEAVAGE PRODUCTS IN PERIPHERAL BLOOD LEUKOCYTES AND CEREBROSPINAL FLUID OF PATIENTS WITH SPORADIC AMYOTROPHIC LATERAL SCLEROSIS 201
A PATIENT WITH FRONTOTEMPORAL DEMENTIA (FTD) AND MOTOR NEURON DISEASE (MND) CARRYING THE INTRON10+29 SUBSTITUTION IN MAPT 200
A novel mutation (Thr116IIe) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease 199
Bilateral Iatrogenic Femoral Neuropathy 197
MARITAL STATUS IS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS 196
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. 195
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 194
A NOVEL ANGIOGENIN GENE MUTATION IN A SPORADIC PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS FROM SOUTHERN ITALY 192
Sleep-wake disturbances in patients with amyotrophic lateral sclerosis 191
The b1 isoform of protocadherin-gamma (Pcdhg) interacts with the microtubule-destabilizing protein SCG10 189
A PATIENT WITH FRONTOTEMPORAL DEMENTIA (FTD) AND MOTOR NEURON DISEASE (MND) CARRYING THE INTRON10+29 SUBSTITUTION IN MAPT . 189
Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat 189
Assessing Command-Following and Communication With Vibro-Tactile P300 Brain-Computer Interface Tools in Patients With Unresponsive Wakefulness Syndrome 187
TELEPHONE FOLLOW-UP FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS 185
Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis 185
Early and rapidly progressing respiratory failure in a patient with amyotrophic lateral sclerosis: when FVC% is misleading 183
SPORADIC PARKINSON DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS COMPLEX (BRAIT-FAHN-SCHWARTZ DISEASE). 182
Post-Translational Modifications in the Survival Motor Neuron Protein 181
Levetiracetam in the Treatment of Creutzfeldt-Jacob Disease. 180
FURTHER EVIDENCE THAT D90A-SOD1 MUTATION IS RECESSIVELY INHERITED IN ALS PATIENTS IN ITALY 180
THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS 179
Architecture of cell differentiation, stress-mediated protein expression and transport in iPSC-derived Motor Neurons bearing a pG376D TDP-43 mutation 179
TOXICITY OF B-N-OXALYLAMINO-L-ALANINE ANDB-N-METHYLAMINO-L-ALANINE IN NIH3T3 CELLS IS MEDIATED BY INHIBITIONOF THE XC¯ ANTIPORTER 178
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study 177
CSF homocysteine levels in Amyotrophic Lateral Sclerosis 175
High frequency of motoneuron dysfunction in FTD: a clinical and electrophysiological study 174
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 173
LA DISFUNZIONE RESPIRATORIA NELLA SCLEROSI LATERALE AMIOTROFICA 173
UNILATERAL LARYNGEAL AND HYPOGLOSSAL PARALYSIS (TAPIA'S SYNDROME) IN A PATIENT WITH AN INFLAMMATORY PSEUDOTUMOR OF THE NECK. 171
CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis 171
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 170
LEVITIRACETAM IN THE TREATMENT OF CREUTZFIELDT-JACOB DISEASE 169
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 168
LONG-LASTING CRANIAL NERVE III PALSY AS A PRESENTING FEATURE OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY 167
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 167
NEUROPHYSIOLOGIC AND CLINICAL SIGNS OF MOTONEURONAL DEGENERATION IN FRONTOTEMPORAL DEMENTIA 166
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 166
URIC ACID LEVELS IN SERUM AND CSF OF ALS PATIENTS 166
ATXN2 trinucleotide repeat length correlates with risk of ALS 166
Performance Differences Using a Vibro-Tactile P300 BCI in LIS-Patients Diagnosed With Stroke and ALS 165
CSF HOMOCYSTEINE LEVELS IN AMYOTROPHC LATERAL SCLEROSIS 163
A PHASE I-II MULTICENTRE STUDY ON G-CSF IN AMYOTROPHIC LATERAL SCLEROSIS (STEMALS) 162
Effects of a Vibro-Tactile P300 Based Brain-Computer Interface on the Coma Recovery Scale-Revised in Patients With Disorders of Consciousness 162
Response to the letter to the Editor: Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis. Safiri S et al 160
DIABETIC THORACIC POLYRADICULOPATHY: A CASE WITH CLINICAL IMPROVEMENT FROM INTRAVENOUS IMMUNOGLOBULIN. 159
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 158
CONSISTENT BONE MARROW-DERIVED CELL MOBILIZATION FOLLOWING REPEATED SHORT COURSES OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: RESULTS FROM A MULTICENTER PROSPECTIVE TRIAL. 158
A PHASE I-II MULTICENTRE STUDY ON G-CSF IN AMYOTROPHIC LATERAL SCLEROSIS 156
E163L HOMOZYGOUS DJ-1 MUTATION IN A FAMILY FROM SOUTHERN ITALY WITH AMIOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX. 153
Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion 153
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 152
RESTLESS LEGS SYNDROME IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A CASE-CONTROL STUDY. 150
A novel S379A TARDBP mutation associated to late-onset sporadic ALS 150
Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D TARDBP mutation 149
SPORADIC ALS IS NOT ASSOCIATED WITH VAPB GENE MUTATIONS IN SOUTHERN ITALY 149
Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management. NEURODEGENERATIVE DISEASE MANAGEMENT 148
Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients 146
Pulmonary function deterioration and chronic hypoventilation in Amyotrophic Lateral Sclerosis 145
ESPRESSIONE DELL’ANTIPORTER CISTINA/GLUTAMMATO XC- NEL SISTEMA NERVOSO DI RATTO 145
SISTEMA NEUROVEGETATIVO; PATOLOGIA E NOTE DI TERAPIA 144
Tumors preceding ALS onset and ALS: results from a case-control study. 144
Totale 20.512
Categoria #
all - tutte 91.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.617 0 402 38 63 69 99 96 81 190 205 109 265
2022/20232.272 232 377 53 236 236 379 161 147 235 82 82 52
2023/20241.276 49 135 121 139 148 230 116 55 25 58 23 177
2024/20252.719 79 191 191 249 129 125 152 161 170 338 374 560
2025/20269.349 647 251 524 606 819 1.299 1.261 960 898 1.425 314 345
2026/2027531 467 64 0 0 0 0 0 0 0 0 0 0
Totale 26.113